Reaction
Ventilation Perfusion Mismatch reporting signals
As of the last recalculation, Ventilation Perfusion Mismatch appears in 273 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is SALMETEROL XINAFOATE (PRR 222.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Salmeterol Xinafoate | 23 | 222.1 | 222.7 |
| Tobramycin Sulfate | 23 | 154.6 | 154.8 |
| Tobramycin Solution | 20 | 136.9 | 137.1 |
| Epoprostenol | 17 | 105.5 | 105.7 |
| Selexipag | 31 | 103.1 | 103.2 |
| Sildenafil Powder, | 31 | 74.8 | 74.9 |
| Sildenafil | 45 | 70.7 | 70.8 |
| Tobramycin | 20 | 68.3 | 68.4 |
| Chlorthalidone | 8 | 54.1 | 54.1 |
| Macitentan | 39 | 49.9 | 50.0 |
| Sildenafil Citrate | 63 | 48.8 | 48.8 |
| Treprostinil | 54 | 40.7 | 40.7 |
| Ranolazine | 5 | 37.2 | 37.2 |
| Ambrisentan | 46 | 33.6 | 33.6 |
| Pirfenidone | 8 | 15.4 | 15.4 |